No One of the following ICD-10-CM is required on the claim: KRAS (Kristen rat sarcoma any viral oncogene homolog) C18.0, C18.2 C20, D01.1, D01.2, D01.40, D01.49, – provider, D37.4 or D37.5 gene analysis; additional except with variant(s) valid TAR override 81283 No ICD-10-CM code B18.2 is required on the claim (except with valid TAR) IFNL3 (interferon, lambda any 3), gene analysis, provider, rs12979860 variant except with valid TAR override 81284 A TAR for CPT code requires documentation of Yes the following criteria: FXN (frataxin) gene analysis; any evaluation to detect The patient has clinical signs or symptoms provider, suspicious for Friedreich ataxia (FRDA), and abnormal alleles except with The patient requires the service as a confirmatory valid TAR test for FRDA override 81285 A TAR for CPT code 81285 requires documentation Yes of the following criteria: FXN (frataxin) gene analysis; any characterization of alleles The patient has clinical signs or symptoms provider, suspicious for Friedreich ataxia (FRDA), and except with The patient requires the service as a confirmatory valid TAR test for FRDA override
KRAS (Kristen rat sarcoma viral oncogene homolog) gene analysis; additional variant(s) No One of the following ICD-10-CM is required on the claim: C18.0, C18.2 – C20, D01.1, D01.2, D01.40, D01.49, D37.4 or D37.5 any provider, except with valid TAR override 81283 IFNL3 (interferon, lambda 3), gene analysis, rs12979860 variant No ICD-10-CM code B18.2 is required on the claim (except with valid TAR) any provider, except with valid TAR override 81284 FXN (frataxin) gene analysis; evaluation to detect abnormal alleles Yes A TAR for CPT code requires documentation of the following criteria: The patient has clinical signs or symptoms suspicious for Friedreich ataxia (FRDA), and The patient requires the service as a confirmatory test for FRDA any provider, except with valid TAR override 81285 FXN (frataxin) gene analysis; characterization of alleles Yes A TAR for CPT code 81285 requires documentation of the following criteria: The patient has clinical signs or symptoms suspicious for Friedreich ataxia (FRDA), and The patient requires the service as a confirmatory test for FRDA any provider, except with valid TAR override